Catechol-O-methyltransferase gene variation: Impact on amygdala response to aversive stimuli

NeuroImage

Volumn 60, Issue 4, 2012, Pages 2222-2229

  Domschke, Katharina ^a,b   Baune, Bernhard T ^c   Havlik, Linda ^a   Stuhrmann, Anja ^a   Suslow, Thomas ^d   Kugel, Harald ^a   Zwanzger, Peter ^a   Grotegerd, Dominik ^a   Sehlmeyer, Christina ^a   Arolt, Volker ^a   Dannlowski, Udo ^a,e  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

5 HTTLPR; Amygdala; Anxiety; COMT; FMRI; Imaging genetics

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ALLELE; AMYGDALOID NUCLEUS; ANGER; ARTICLE; AVERSIVE BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EMOTION; FEAR; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MALE; MENTAL DISEASE; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECOGNITION;

ADULT; AMYGDALA; BRAIN MAPPING; CATECHOL O-METHYLTRANSFERASE; EMOTIONS; FACE; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHOTIC STIMULATION; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX CHARACTERISTICS;

EID: 84858734586     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.02.039     Document Type: Article

References (129)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
2. Arias B., Serretti A., Lorenzi C., Gastó C., Catalán R., Fañanás L. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. J. Affect. Disord. 2006, 90(2-3):251-256.
3. Baas D., Aleman A., Kahn R.S. Lateralization of amygdala activation: a systematic review of functional neuroimaging studies. Brain Res. Brain Res. Rev. 2004, 45(2):96-103.
4. Baeken C., Van Schuerbeek P., De Raedt R., Bossuyt A., Vanderhasselt M.A., De Mey J., Luypaert R. Passively viewing negatively valenced baby faces attenuates left amygdala activity in healthy females scoring high on 'Harm Avoidance'. Neurosci. Lett. 2010, 478(2):97-101.
5. Baekken P.M., Skorpen F., Stordal E., Zwart J.A., Hagen K. Depression and anxiety in relation to catechol-O-methyltransferase Val158Met genotype in the general population: the Nord-Trøndelag Health Study (HUNT). BMC Psychiatry 2008, 8:48.
6. Baffa A., Hohoff C., Baune B.T., Müller-Tidow C., Tidow N., Freitag C., Zwanzger P., Deckert J., Arolt V., Domschke K. Norepinephrine and serotonin transporter genes: impact on treatment response in depression. Neuropsychobiology 2010, 62:121-131.
7. Baune B.T., Hohoff C., Mortensen L.S., Deckert J., Arolt V., Domschke K. Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect?. Depress Anxiety 2008, 25(11):920-925.
8. Baune B.T., Hohoff C., Berger K., Neumann A., Mortensen S., Roehrs T., Deckert J., Arolt V., Domschke K. Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology 2008, 33(4):924-932.
9. Beck A.T. Cognitive Therapy and the emotional disorders 1976, International Univ. Press, New York.
10. Beck A.T., Steer R.A. Beck Depression Inventory: Manual 1987, Psychological Corporation Harcourt Brace Jovanovich, San Antonio, TX.
11. Bilder R.M., Volavka J., Lachman H.M., Grace A.A. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004, 29(11):1943-1961.
12. Boudikova B., Szumlanski C., Maidak B., Weinshilboum R. Human liver catechol-O-methyltransferase pharmacogenetics. Clin. Pharmacol. Ther. 1990, 48:381-389.
13. Bradley B.P., Mogg K., Millar N., White J. Selective processing of negative information: effects of clinical anxiety, concurrent depression, and awareness. J. Abnorm. Psychol. 1995, 104(3). (Aug), 532-536.
14. Bryant R.A., Kemp A.H., Felmingham K.L., Liddell B., Olivieri G., Peduto A., Gordon E., Williams L.M. Enhanced amygdala and medial prefrontal activation during nonconscious processing of fear in posttraumatic stress disorder: an fMRI study. Hum. Brain Mapp. 2008, 29(5):517-523.
15. Buckholtz J.W., Sust S., Tan H.Y., Mattay V.S., Straub R.E., Meyer-Lindenberg A., Weinberger D.R., Callicott J.H. fMRI evidence for functional epistasis between COMT and RGS4. Mol. Psychiatry 2007, 12(10):893-895. (885).
16. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., Kolachana B.S., Hyde T.M., Herman M.M., Apud J., Egan M.F., Kleinman J.E., Weinberger D.R. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 2004, 75(5):807-821.
17. Cloninger C.R. A systematic method for clinical description and classification of personality variants. A proposal. Arch. Gen. Psychiatry 1987, 44:573-588.
18. Comasco E., Sylvén S.M., Papadopoulos F.C., Sundström-Poromaa I., Oreland L., Skalkidou A. Postpartum depression symptoms: a case-control study on monoaminergic functional polymorphisms and environmental stressors. Psychiatr. Genet. 2011, 21(1):19-28.
19. Conway C.C., Hammen C., Brennan P.A., Lind P.A., Najman J.M. Interaction of chronic stress with serotonin transporter and catechol-O-methyltransferase polymorphisms in predicting youth depression. Depress. Anxiety 2010, 27(8):737-745.
20. Critchley H., Daly E., Phillips M., Brammer M., Bullmore E., Williams S., Van Amelsvoort T., Robertson D., David A., Murphy D. Explicit and implicit neural mechanisms for processing of social information from facial expressions: a functional magnetic resonance imaging study. Hum. Brain Mapp. 2000, 9(2):93-105.
21. Cusin C., Serretti A., Lattuada E., Lilli R., Lorenzi C., Smeraldi E. Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders. Am. J. Med. Genet. 2002, 114(4):380-390.
22. Dannlowski U., Ohrmann P., Bauer J., Kugel H., Baune B.T., Hohoff C., Kersting A., Arolt V., Heindel W., Deckert J., Suslow T. Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav. 2007, 6(7):672-676.
23. Dannlowski U., Ohrmann P., Bauer J., Deckert J., Hohoff C., Kugel H., Arolt V., Heindel W., Kersting A., Baune B.T., Suslow T. 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology 2008, 33(2):418-424.
24. Dannlowski U., Ohrmann P., Konrad C., Domschke K., Bauer J., Kugel H., Hohoff C., Schöning S., Kersting A., Baune B.T., Mortensen L.S., Arolt V., Zwitserlood P., Deckert J., Heindel W., Suslow T. Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int. J. Neuropsychopharmacol. 2009, 12(1):11-22.
25. Dannlowski U., Konrad C., Kugel H., Zwitserlood P., Domschke K., Schöning S., Ohrmann P., Bauer J., Pyka M., Hohoff C., Zhang W., Baune B.T., Heindel W., Arolt V., Suslow T. Emotion specific modulation of automatic amygdala responses by 5-HTTLPR genotype. Neuroimage 2010, 53(3):893-898.
26. Dannlowski U., Kugel H., Franke F., Stuhrmann A., Hohoff C., Zwanzger P., Lenzen T., Grotegerd D., Suslow T., Arolt V., Heindel W., Domschke K. Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli. Neuropsychopharmacology 2011, 36(9):1879-1885.
27. Dannlowski U., Stuhrmann A., Beutelmann V., Zwanzger P., Lenzen T., Grotegerd D., Domschke K., Hohoff C., Ohrmann P., Bauer J., Lindner C., Postert C., Konrad C., Arolt V., Heindel W., Suslow T., Kugel H. Limbic scars: long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging. Biol. Psychiatry 2012, 71(4). (Feb 15), 286-293.
28. Domschke K., Dannlowski U. Imaging genetics of anxiety disorders. Neuroimage 2010, 53(3):822-831.
29. Domschke K., Freitag C.M., Kuhlenbäumer G., Schirmacher A., Sand P., Nyhuis P., Jacob C., Fritze J., Franke P., Rietschel M., Garritsen H.S., Fimmers R., Nöthen M.M., Lesch K.P., Stögbauer F., Deckert J. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int. J. Neuropsychopharmacol. 2004, 7(2):183-188.
30. Domschke K., Deckert J., O'Donovan M.C., Glatt S.J. Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B(5):667-673.
31. Domschke K., Ohrmann P., Braun M., Suslow T., Bauer J., Hohoff C., Kersting A., Engelien A., Arolt V., Heindel W., Deckert J., Kugel H. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res. 2008, 163(1):13-20.
32. Domschke K., Zavorotnyy M., Diemer J., Nitsche S., Hohoff C., Baune B.T., Deckert J., Arolt V., Zwanzger P. COMT val158met influence on electroconvulsive therapy response in major depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(1):286-290.
33. Domschke K., Dannlowski U., Hohoff C., Ohrmann P., Bauer J., Kugel H., Zwanzger P., Heindel W., Deckert J., Arolt V., Suslow T., Baune B.T. Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression. Eur. Neuropsychopharmacol. 2010, 20(5):301-309.
34. Drabant E.M., Hariri A.R., Meyer-Lindenberg A., Munoz K.E., Mattay V.S., Kolachana B.S., Egan M.F., Weinberger D.R. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch. Gen. Psychiatry 2006, 63(12):1396-1406.
35. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(12):6917-6922.
36. Ekman P., Friesen W.V. Pictures of Facial Affect 1976, Consulting Psychologists Press, Palo Alto.
37. Eley T.C., Tahir E., Angleitner A., Harriss K., McClay J., Plomin R., Riemann R., Spinath F., Craig I. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 120B(1):90-96.
38. Enoch M.A., Xu K., Ferro E., Harris C.R., Goldman D. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr. Genet. 2003, 13(1):33-41.
39. Enoch M.A., White K.V., Waheed J., Goldman D. Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders. Depress. Anxiety 2008, 25(5):383-392.
40. Etkin A., Schatzberg A.F. Common abnormalities and disorder-specific compensation during implicit regulation of emotional processing in generalized anxiety and major depressive disorders. Am. J. Psychiatry 2011, 168(9):968-978.
41. Etkin A., Wager T.D. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am. J. Psychiatry 2007, 164(10):1476-1488.
42. Etkin A., Klemenhagen K.C., Dudman J.T., Rogan M.T., Hen R., Kandel E.R., Hirsch J. Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 2004, 44(6):1043-1055.
43. Evans K.C., Wright C.I., Wedig M.M., Gold A.L., Pollack M.H., Rauch S.L. A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder. Depress. Anxiety 2008, 25(6):496-505.
44. Fähndrich E., Coper H., Christ W., Helmchen H., Müller-Oerlinghausen B., Pietzcker A. Erythrocyte COMT-activity in patients with affective disorders. Acta Psychiatr. Scand. 1980, 61(5):427-437.
45. Fakra E., Hyde L.W., Gorka A., Fisher P.M., Muñoz K.E., Kimak M., Halder I., Ferrell R.E., Manuck S.B., Hariri A.R. Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch. Gen. Psychiatry 2009, 66:33-40.
46. Faul F., Erdfelder E., Lang A.-G., Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 2007, 39:175-191.
47. Forman S.D., Cohen J.D., Fitzgerald M., Eddy W.F., Mintun M.A., Noll D.C. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn. Reson. Med. 1995, 33:636-647.
48. Frisch A., Postilnick D., Rockah R., Michaelovsky E., Postilnick S., Birman E., Laor N., Rauchverger B., Kreinin A., Poyurovsky M., Schneidman M., Modai I., Weizman R. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol. Psychiatry 1999, 4(4):389-392.
49. Funke B., Malhotra A.K., Finn C.T., Plocik A.M., Lake S.L., Lencz T., DeRosse P., Kane J.M., Kucherlapati R. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav. Brain Funct. 2005, 1:19.
50. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160:636-645.
51. Hamilton S.P., Slager S.L., Heiman G.A., Deng Z., Haghighi F., Klein D.F., Hodge S.E., Weissman M.M., Fyer A.J., Knowles J.A. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol. Psychiatry 2002, 51(7):591-601.
52. Hariri A.R., Bookheimer S.Y., Mazziotta J.C. Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport 2000, 11(1):43-48.
53. Hariri A.R., Tessitore A., Mattay V.S., Fera F., Weinberger D.R. The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 2002, 17:317-323.
54. Hariri A.R., Mattay V.S., Kolachana B.S., Tessitore A., Fera F., Goldman D., Egan M.F., Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
55. Hariri A.R., Drabant E.M., Muñoz K.E., Kolachana B.S., Mattay V.S., Egan M.F., Weinberger D.R. A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry 2005, 62:146-152.
56. Harmer C.J., Shelley N.C., Cowen P.J., Goodwin G.M. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am. J. Psychiatry 2004, 161(7):1256-1263.
57. Harrison P.J., Tunbridge E.M. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2008, 33(13):3037-3045.
58. Henderson A.S., Korten A.E., Jorm A.F., Jacomb P.A., Christensen H., Rodgers B., Tan X., Easteal S. COMT and DRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders. Am. J. Med. Genet. 2000, 96(1):102-107.
59. Hettema J.M., An S.S., Bukszar J., van den Oord E.J., Neale M.C., Kendler K.S., Chen X. Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biol. Psychiatry 2008, 64(4):302-310.
60. Hung Y., Smith M.L., Bayle D.J., Mills T., Cheyne D., Taylor M.J. Unattended emotional faces elicit early lateralized amygdala-frontal and fusiform activations. Neuroimage 2010, 50(2):727-733.
61. Karege F., Bovier P., Gaillard J.M., Tissot R. The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance. Acta Psychiatr. Scand. 1987, 76(3):303-308.
62. Kempton M.J., Haldane M., Jogia J., Christodoulou T., Powell J., Collier D., Williams S.C., Frangou S. The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study. Int. J. Neuropsychopharmacol. 2009, 12(3):371-381.
63. Kim S.J., Kim Y.S., Kim S.Y., Lee H.S., Kim C.H. An association study of catechol-O-methyltransferase and monoamine oxidase A polymorphisms and personality traits in Koreans. Neurosci. Lett. 2006, 401(1-2):154-158.
64. Kolassa I.T., Kolassa S., Ertl V., Papassotiropoulos A., De Quervain D.J. The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val(158)Met polymorphism. Biol. Psychiatry 2010, 67(4):304-308.
65. Kunugi H., Vallada H.P., Hoda F., Kirov G., Gill M., Aitchison K.J., Ball D., Arranz M.J., Murray R.M., Collier D.A. No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biol. Psychiatry 1997, 42(4):282-285.
66. Lachman H.M., Morrow B., Shprintzen R., Veit S., Parsia S.S., Faedda G., Goldberg R., Kucherlapati R., Papolos D.F. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 1996, 67:468-472.
67. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., Kochunov P.V., Nickerson D., Mikiten S.A., Fox P.T. Automated Talairach atlas labels for functional brain mapping. Hum. Brain Mapp. 2000, 10:120-131.
68. Laux L., Glanzmann P., Schaffner P., Spielberger C.D. Das State-Trait Angstinventar 1981, Beltz, Weinheim, Germany.
69. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest MWT-B 1995, Hogrefe, Göttingen.
70. Lelli-Chiesa G., Kempton M.J., Jogia J., Tatarelli R., Girardi P., Powell J., Collier D.A., Frangou S. The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives. Psychol. Med. 2011, 41(4):779-788.
71. Leppänen J.M. Emotional information processing in mood disorders: a review of behavioral and neuroimaging findings. Curr. Opin. Psychiatry 2006, 19(1):34-39.
72. Liu B., Song M., Li J., Liu Y., Li K., Yu C., Jiang T. Prefrontal-related functional connectivities within the default network are modulated by COMT val158met in healthy young adults. J. Neurosci. 2010, 30(1):64-69.
73. Lonsdorf T.B., Rück C., Bergström J., Andersson G., Ohman A., Lindefors N., Schalling M. The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder. BMC Psychiatry 2010, 10:99.
74. Lonsdorf T.B., Golkar A., Lindstöm K.M., Fransson P., Schalling M., Ohman A., Ingvar M. 5-HTTLPR and COMTval158met genotype gate amygdala reactivity and habituation. Biol. Psychol. 2011, 87(1):106-112.
75. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003, 19:1233-1239.
76. Mandelli L., Serretti A., Marino E., Pirovano A., Calati R., Colombo C. Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. Int. J. Neuropsychopharmacol. 2007, 10(4):437-447.
77. Männistö P.T., Lang A., Rauhala P., Vasar E. Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression. Eur. J. Pharmacol. 1995, 274(1-3):229-233.
78. Massat I., Souery D., Del-Favero J., Nothen M., Blackwood D., Muir W., Kaneva R., Serretti A., Lorenzi C., Rietschel M., Milanova V., Papadimitriou G.N., Dikeos D., Van Broekhoven C., Mendlewicz J. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol. Psychiatry 2005, 10(6):598-605.
79. Mathew R.J., Ho B.T., Kralik P., Taylor D., Claghorn J.L. MAO, DBH and COMT: the effect of anxiety. J. Clin. Psychiatry 1980, 41(12 Pt 2):25-28.
80. McGrath M., Kawachi I., Ascherio A., Colditz G.A., Hunter D.J., De Vivo I. Association between catechol-O-methyltransferase and phobic anxiety. Am. J. Psychiatry 2004, 161(9):1703-1705.
81. Meyer-Lindenberg A., Nichols T., Callicott J.H., Ding J., Kolachana B., Buckholtz J., Mattay V.S., Egan M., Weinberger D.R. Impact of complex genetic variation in COMT on human brain function. Mol. Psychiatry 2006, 11(9):867-877.
82. Meyer-Lindenberg A., Kolachana B.S., Buckholtz J.W., Hariri A.R., Pezawas L., Blasi G., Wabnitz A., Verchinski B.A., Honea R., Egan M.F., Callicott J.H., Mattay V.S., Weinberger D.R. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6269-6274.
83. Mier D., Kirsch P., Meyer-Lindenberg A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol. Psychiatry 2010, 15(9):918-927.
84. Munafò M.R., Brown S.M., Hariri A.R. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol. Psychiatry 2008, 63(9):852-857.
85. Nackley A.G., Shabalina S.A., Tchivileva I.E., Satterfield K., Korchynskyi O., Makarov S.S., Maixner W., Diatchenko L. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006, 314(5807):1930-1933.
86. Nicodemus K.K., Kolachana B.S., Vakkalanka R., Straub R.E., Giegling I., Egan M.F., Rujescu D., Weinberger D.R. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum. Genet. 2006, 120(6):889-906.
87. Norbury R., Mackay C.E., Cowen P.J., Goodwin G.M., Harmer C.J. Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. Br. J. Psychiatry 2007, 190:531-532.
88. Oeth P., Beaulieu M., Park C., Kosman D., del Mistro G., van den Boom D., Jurinke C. iPLEX™ Assay: Increased Plexing Efficiency and Flexibility for MassARRAY System through Single Base Primer Extension with Mass-modified Terminators 2007.
89. Ohara K., Nagai M., Suzuki Y., Ochiai M., Ohara K. No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res. 1998, 80(2):145-148.
90. Olsson C.A., Anney R.J., Lotfi-Miri M., Byrnes G.B., Williamson R., Patton G.C. Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health. Psychiatr. Genet. 2005, 15:109-115.
91. Olsson C.A., Byrnes G.B., Anney R.J., Collins V., Hemphill S.A., Williamson R., Patton G.C. COMT Val(158)Met and 5HTTLPR functional loci interact to predict persistence of anxiety across adolescence: results from the Victorian Adolescent Health Cohort Study. Genes Brain Behav. 2007, 6(7):647-652.
92. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Muñoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005, 8:828-834.
93. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol. Psychiatry 2003, 54(5):515-528.
94. Puls I., Mohr J., Wrase J., Vollstädt-Klein S., Leménager T., Vollmert C., Rapp M., Obermayer K., Heinz A., Smolka M.N. A model comparison of COMT effects on central processing of affective stimuli. Neuroimage 2009, 46(3):683-691.
95. Puzynski S., Bidzinski A., Mrozek S., Zaluska M. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. II. Erythrocyte catechol-O-methyltransferase activity in endogenous depression. Acta Psychiatr. Scand. 1983, 67(2):96-100.
96. Rasch B., Spalek K., Buholzer S., Luechinger R., Boesiger P., de Quervain D.J., Papassotiropoulos A. Aversive stimuli lead to differential amygdala activation and connectivity patterns depending on catechol-O-methyltransferase Val158Met genotype. Neuroimage 2010, 52(4):1712-1719.
97. Rauch S.L., Shin L.M., Wright C.I. Neuroimaging studies of amygdala function in anxiety disorders. Ann. N. Y. Acad. Sci. 2003, 985:389-410.
98. Rauch S.L., Whalen P.J., Shin L.M., McInerney S.C., Macklin M.L., Lasko N.B., Orr S.P., Pitman R.K. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol. Psychiatry 2000, 47(9). (May 1), 769-776.
99. Remy P., Doder M., Lees A., Turjanski N., Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005, 128:1314-1322.
100. Richard I.H., Schiffer R.B., Kurlan R. Anxiety and Parkinson's disease. J. Neuropsychiatry Clin. Neurosci. 1996, 8:383-392.
101. Rothe C., Koszycki D., Bradwejn J., King N., Deluca V., Tharmalingam S., Macciardi F., Deckert J., Kennedy J.L. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology 2006, 31(10):2237-2242.
102. Rudrauf D., David O., Lachaux J.P., Kovach C.K., Martinerie J., Renault B., Damasio A. Rapid interactions between the ventral visual stream and emotion-related structures rely on a two-pathway architecture. J. Neurosci. 2008, 28(11):2793-2803.
103. Samochowiec J., Hajduk A., Samochowiec A., Horodnicki J., Stepieńm G., Grzywacz A., Kucharska-Mazur J. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res. 2004, 128(1):21-26.
104. Scharinger C., Rabl U., Sitte H.H., Pezawas L. Imaging genetics of mood disorders. Neuroimage 2010, 53(3):810-821.
105. Sehlmeyer C., Dannlowski U., Schöning S., Kugel H., Pyka M., Pfleiderer B., Zwitserlood P., Schiffbauer H., Heindel W., Arolt V., Konrad C. Neural correlates of trait anxiety in fear extinction. Psychol. Med. 2010, 41(4):789-798.
106. Serretti A., Cusin C., Cristina S., Lorenzi C., Lilli R., Lattuada E., Grieco G., Costa A., Santorelli F., Barale F., Smeraldi E., Nappi G. Multicentre Italian family-based association study on tyrosine hydroxylase, catechol-O-methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders. Psychiatr. Genet. 2003, 13(2):121-126.
107. Shin L.M., Wright C.I., Cannistraro P.A., Wedig M.M., McMullin K., Martis B., Macklin M.L., Lasko N.B., Cavanagh S.R., Krangel T.S., Orr S.P., Pitman R.K., Whalen P.J., Rauch S.L. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch. Gen. Psychiatry 2005, 62(3):273-281.
108. Shulman R., Griffiths J., Diewold P. Catechol-O-methyltransferase activity in patients with depressive illness and anxiety states. Br. J. Psychiatry 1978, 132:133-138.
109. Simon N.M., Emmanuel N., Ballenger J., Worthington J.J., Kinrys G., Korbly N.B., Farach F.J., Pollack M.H. Bupropion sustained release for panic disorder. Psychopharmacol. Bull. 2003, 37:66-72.
110. Smolka M.N., Schumann G., Wrase J., Grüsser S.M., Flor H., Mann K., Braus D.F., Goldman D., Büchel C., Heinz A. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J. Neurosci. 2004, 25(4):836-842.
111. Smolka M.N., Bühler M., Schumann G., Klein S., Hu X.Z., Moayer M., Zimmer A., Wrase J., Flor H., Mann K., Braus D.F., Goldman D., Heinz A. Gene-gene effects on central processing of aversive stimuli. Mol. Psychiatry 2007, 12(3):307-317.
112. Stein M.B., Fallin M.D., Schork N.J., Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 2005, 30(11):2092-2102.
113. Suslow T., Konrad C., Kugel H., Rumstadt D., Zwitserlood P., Schöning S., Ohrmann P., Bauer J., Pyka M., Kersting A., Arolt V., Heindel W., Dannlowski U. Automatic mood-congruent amygdala responses to masked facial expressions in major depression. Biol. Psychiatry 2010, 67(2):155-160. (Jan 15).
114. Szegedi A., Rujescu D., Tadic A., Müller M.J., Kohnen R., Stassen H.H., Dahmen N. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenomics J. 2005, 5(1):49-53.
115. Tan H.Y., Chen Q., Sust S., Buckholtz J.W., Meyers J.D., Egan M.F., Mattay V.S., Meyer-Lindenberg A., Weinberger D.R., Callicott J.H. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(30):12536-12541.
116. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
117. Ursini G., Bollati V., Fazio L., Porcelli A., Lacovelli L., Catalani A., Sinibaldi L., Gelao B., Romano R., Rampino A., Taurisano P., Mancini M., Di Giorgio A., Popolizio T., Baccarelli A., De Blasi A., Blasi G., Bertolino A. Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J. Neurosci. 2011, 31(18):6692-6698.
118. Wager T.D., Phan K.L., Liberzon I., Taylor S.F. Valence, gender, and lateralization of functional brain anatomy in emotion: a meta-analysis of findings from neuroimaging. Neuroimage 2003, 19(3):513-531.
119. Weiss E.M., Stadelmann E., Kohler C.G., Brensinger C.M., Nolan K.A., Oberacher H., Parson W., Pitterl F., Niederstätter H., Kemmler G., Hinterhuber H., Marksteiner J. Differential effect of catechol-O-methyltransferase Val158Met genotype on emotional recognition abilities in healthy men and women. J. Int. Neuropsychol. Soc. 2007, 13(5):881-887.
120. Weissman M.M., Bland R.C., Canino G.J., Faravelli C., Greenwald S., Hwu H.G., Joyce P.R., Karam E.G., Lee C.K., Lellouch J., Lepine J.P., Newman S.C., Oakley-Browne M.A., Rubio-Stipec M., Wells J.E., Wickramaratne P.J., Wittchen H.U., Yeh E.K. The cross-national epidemiology of panic disorder. Arch. Gen. Psychiatry 1997, 54:305-309.
121. Wendland J., Martin B., Kruse M., Lesch K., Murphy D. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol. Psychiatry 2006, 11(3):224-226.
122. Williams L.M., Gatt J.M., Grieve S.M., Dobson-Stone C., Paul R.H., Gordon E., Schofield P.R. COMT Val(108/158)Met polymorphism effects on emotional brain function and negativity bias. Neuroimage 2010, 53(3). (Nov 15), 918-925.
123. Winqvist R., Lundström K., Salminen M., Laatikainen M., Ulmanen I. The human catechol-O-methyltransferase (COMT) gene maps to band q11.2 of chromosome 22 and shows a frequent RFLP with BglI. Cytogenet Cell Genet. 1992, 59(4):253-257.
124. Wittchen H.-U., Wunderlich U., Gruschwitz S., Zaudig M. SKID-I. Strukturiertes Klinisches Interview für DSM-IV 1997, Hogrefe, Göttingen.
125. Woo J.M., Yoon K.S., Choi Y.H., Oh K.S., Lee Y.S., Yu B.H. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J. Psychiatr. Res. 2004, 38(4):365-370.
126. Wray N.R., James M.R., Dumenil T., Handoko H.Y., Lind P.A., Montgomery G.W., Martin N.G. Association study of candidate variants of COMT with neuroticism, anxiety and depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(7):1314-1318.
127. Wright C.I., Fischer H., Whalen P.J., McInerney S.C., Shin L.M., Rauch S.L. Differential prefrontal cortex and amygdala habituation to repeatedly presented emotional stimuli. Neuroreport 2001, 12(2):379-383.
128. Xie T., Ho S.L., Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol. Pharmacol. 1999, 56:31-38.
129. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.